Oura Health Files Confidentially for IPO Signaling Move Toward Public Markets Healthcare and Tech Lead SP 500 to Modest Gains as Communication Services Lags Stratasys to Acquire Markforged Consolidating Additive Manufacturing Industry IRS Tax Refund Deadline Millions of Americans May Have Unclaimed COVIDEra Payments Chinas Deadliest Coal Mining Disaster in Years Sparks Public Anger and Safety Concerns Oil Prices Tumble Over 5 as Iran Nuclear Deal Prospects Weigh on Market Capstone Holding Corp CAPS Q4 2025 Earnings Massive EPS Miss Sends Stock Higher A Contradictory Market Reaction RDY Q1 2026 Earnings Significant EPS Miss Amid Challenging Quarter RDHL Q2 2022 Earnings Significant EPS Miss as Company Reports Zero Revenue BWA Q1 2026 Earnings EPS Beats Estimates Shares Rise SM Energy Q1 2026 Earnings Strong EPS Beat Amid Market Headwinds CCNE Q1 2026 Earnings EPS Beats Estimates Amidst Mixed Market Reaction Bluelinx Holdings BXC Gains Ground Testing Key Resistance at 5222 AutoZone AZO Slips Modestly Amidst Consolidation Near Key Resistance Dicks Sporting Goods DKS Edges Higher Resistance Level in Focus Champion Homes SKY Rises 11 Approaching Key Resistance Smart Sand Inc SND Drifts Higher as Stock Tests Key Resistance Near 521 One House Three Owners How Homeownership Costs Have Risen Across Generations DMC Global BOOM Q1 2026 Earnings Surprise EPS Beat Amid Persistent Headwinds Silgan Holdings SLGN Holds Steady Near 38 as Shares Consolidate Between Key Support and Resistance CGEN Q1 2026 Earnings EPS Misses Estimates but Stock Rises 728 on Pipeline Progress CZNC Q1 2026 Earnings Massive EPS Miss Amid Surprising Stock Resilience FVCBankcorp Inc Q1 2026 Earnings EPS Beats Estimates by 4 Amid Challenging Banking Landscape Regency Centers Corporation 625 Series A Cumulative Redeemable Preferred Stock REGCP Q1 2026 Earnings Strong EPS Beat Signals Steady Preferred Dividend Coverage SBSI Q1 2026 Earnings EPS Beat of 422 Despite Tightening Margin Environment BBAR Q4 2025 Earnings Earnings Beat Estimates Despite Stock Decline Indaptus Therapeutics Inc INDP Q4 2025 Earnings Deeper Loss Yet Shares Surge on Pipeline Progress